CARIVALAN 6.25/7.5MG 28 F.C. TABS

Carivalan is indicated as substitution therapy in adult patients with normal sinus rhythm already controlled by ivabradine and carvedilol taken concomitantly at the same doses level for: - the symptomatic treatment of chronic stable angina pectoris in coronary artery disease patients - the treatment of chronic heart failure (II-IV NYHA-class) with systolic dysfunction. The recommended dose of Carivalan is one tablet twice daily once in the morning and once in the evening.